Paul Moore, MD
Urogynecology and Reconstructive Pelvic Surgery · Jackson, MSNPI 1962679241
Payments from drug & device makers
Across 166 payments — averaging $87.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gynesonics, Inc.$6K
- Intuitive Surgical$4K
- Medtronic$1K
- Axonics, Inc.$888
- AbbVie$817
- Sumitomo Pharma America, Inc.$207
- plus $1K from 24 others
Across 2 payments — averaging $4502.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gynesonics, Inc.$9K
What the payments were for
- Travel & lodging$1,62019%
- Food & beverage$4,47952%
- Education$2,50029%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gynesonics, Inc. | 1 | $5,895 |
| Intuitive Surgical | 12 | $3,940 |
| Medtronic(2 entities) | 36 | $1,335 |
| Axonics, Inc. | 22 | $888 |
| AbbVie(2 entities) | 31 | $817 |
| Sumitomo Pharma America, Inc. | 11 | $207 |
| Astellas Pharma US Inc | 4 | $197 |
| Boston Scientific | 7 | $142 |
| Urovant Sciences Inc | 9 | $138 |
| Davol Inc. | 2 | $137 |
| Caldera Medical, Inc | 2 | $127 |
| Procept Biorobotics Corporation | 2 | $87 |
| Coloplast | 4 | $78 |
| Urogen Pharma, Inc. | 3 | $65 |
| Bayer | 3 | $62 |
| Abbott | 1 | $50 |
| Applied Medical Resources Corporation | 1 | $43 |
| Ferring Pharmaceuticals Inc. | 2 | $39 |
| Steris Corporation | 1 | $33 |
| Laborie Medical Technologies Corp. | 2 | $28 |
| Tempus AI, Inc | 1 | $25 |
| Merck | 1 | $22 |
| Dendreon Pharmaceuticals LLC | 1 | $20 |
| Eisai Inc. | 1 | $20 |
| ABC Home Medical Supply, Inc. | 1 | $19 |
| Hollister Incorporated | 1 | $19 |
| Pfizer | 1 | $19 |
| Progenics Pharmaceuticals, Inc. | 1 | $17 |
| Mission Pharmacal Company | 1 | $16 |
| Exeltis, USA Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$2,500
- Da Vinci Surgical System$1,282
- Axonics$606
- INTERSTIM$431
- BOTOX$386
- MYRBETRIQ$125
- Desara$110
- ARISTA AH FLEXITIP$105
- Orilissa$102
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 283 | $151,864 |
| GemtesaVibegron | 231 | $141,002 |
| Estradiol | 231 | $15,108 |
| Mirabegron ErMirabegron | 18 | $7,811 |
| Methenamine Hippurate | 90 | $6,114 |
| Trimethoprim | 43 | $2,247 |
| Lo Loestrin FeNorethindrone-E.Estradiol-Iron | 12 | $2,016 |
| NitrofurantoinNitrofurantoin Macrocrystal | 48 | $1,325 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 102 | $1,202 |
| Oxybutynin Chloride ErOxybutynin Chloride | 30 | $729 |
| Cephalexin | 104 | $618 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 102 | $469 |
| Gabapentin | 19 | $291 |
| Fluconazole | 45 | $226 |
| Amitriptyline Hcl | 31 | $213 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $197 | $151,864283 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $207 | $141,002231 claims |
| AbbVieLo Loestrin Fe | $817 | $2,01612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few urogynecology and reconstructive pelvic surgery providers in Mississippion file to place this against a meaningful peer group, so we don't.
Other urogynecology and reconstructive pelvic surgery in Jackson
- Thomas PitmanSouthaven$156K
- Steven SpeightsFlowood$45K
- John BatenFlowood$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.